Resuscitation
Volume 81, Issue 1 , Pages 47-52, January 2010

Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia☆

  • Tsuyoshi Shiga

      Affiliations

    • Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3353 8111; fax: +81 3 3356 0441.
    • ,
  • Keiji Tanaka

      Affiliations

    • Intensive and Cardiac Care Unit, Nippon Medical School, Tokyo, Japan
    • ,
  • Rinya Kato

      Affiliations

    • Department of Cardiology, Nagoya Ekisaikai Hospital, Nagoya, Japan
    • ,
  • Mari Amino

      Affiliations

    • Department of Cardiology, Tokai University School of Medicine, Isehara, Japan
    • ,
  • Yuji Matsudo

      Affiliations

    • Department of Cardiology, Kimitsu Chuo Hospital, Kisarazu, Japan
    • ,
  • Toshihiro Honda

      Affiliations

    • Department of Cardiology, Saisei-kai Kumamoto Hospital, Kumamoto, Japan
    • ,
  • Koichi Sagara

      Affiliations

    • Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan
    • ,
  • Atsushi Takahashi

      Affiliations

    • Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
    • ,
  • Takao Katoh

      Affiliations

    • Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
    • ,
  • Mitsuyoshi Urashima

      Affiliations

    • Division of Molecular Epidemiology, Jikei University School of Medicine, Tokyo, Japan
    • ,
  • Satoshi Ogawa

      Affiliations

    • International University of Health and Welfare Mita Hospital, Tokyo, Japan
    • ,
  • Teruo Takano

      Affiliations

    • Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
    • ,
  • Hiroshi Kasanuki

      Affiliations

    • Faculty of Science and Engineering, Waseda University, Tokyo, Japan
    • ,
  • for the Refractory VT/VF, Prospective Evaluation to Differentiate Lidocaine Efficacy from Nifekalant (RELIEF) Study Investigators

Received 6 June 2009; received in revised form 15 August 2009; accepted 20 September 2009. published online 16 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ A Spanish translated version of the abstract of this article appears as Appendix in the online version at doi:10.1016/j.resuscitation.2009.09.027.

PII: S0300-9572(09)00503-6

doi:10.1016/j.resuscitation.2009.09.027

Resuscitation
Volume 81, Issue 1 , Pages 47-52, January 2010

Article Tools